Fees Jessica
Chief Financial Officer at Surface Oncology, Inc.
- Sold, on record
- $176k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Aug 1, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Surface Oncology, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Surface Oncology, Inc.Plan not statedFeb 1, 2021 2021
Sold 1,500 shares at $11.19 ($17k)
Fees Jessica, Officer
Sold 1.5% of holdings ($1.1M position)100,683 shares leftFirst sale on recordFiling
- 2 Form 4 sale Surface Oncology, Inc.Plan not statedFeb 8, 2021 +7 days
Sold 1,500 shares at $12.45 ($19k)
Fees Jessica, Officer
Sold 1.5% of holdings ($1.3M position)99,183 shares leftFiling
- 3 Form 4 sale Surface Oncology, Inc.Plan not statedJul 21, 2021 +163 days
Sold 19,854 shares at $6.10 ($121k)
Fees Jessica, Chief Financial Officer
Sold 20% of holdings ($605k position)79,329 shares leftFiling
- 4 Form 4 sale Surface Oncology, Inc.UnusualAug 3, 2022 +378 days
Sold 5,980 shares at $1.72 ($10k)
Fees Jessica, Chief Financial Officer
Sold 5.1% of holdings ($202k position)111,349 shares left4x usual sizeFiling
- 5 Form 4 sale Surface Oncology, Inc.No planAug 1, 2023 +363 days
Sold 9,434 shares at $0.94 ($9k)
Fees Jessica, Chief Financial Officer
No 10b5-1 planSold 8.5% of holdings ($105k position)101,915 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | Aug 11, 2023 | Surface Oncology, Inc. | Chief Financial Officer | Form 4 sale | 9,434 | $9k | 8.5% | No plan | SEC |
| Aug 3, 2022 | Aug 5, 2022 | Surface Oncology, Inc. | Chief Financial Officer | Form 4 sale | 5,980 | $10k | 5.1% | Unusual | SEC |
| Jul 21, 2021 | Jan 14, 2022 | Surface Oncology, Inc. | Chief Financial Officer | Form 4 sale | 19,854 | $121k | 20.0% | Plan not stated | SEC |
| Feb 8, 2021 | Feb 9, 2021 | Surface Oncology, Inc. | Officer | Form 4 sale | 1,500 | $19k | 1.5% | Plan not stated | SEC |
| Feb 1, 2021 | Feb 3, 2021 | Surface Oncology, Inc. | Officer | Form 4 sale | 1,500 | $17k | 1.5% | Plan not stated | SEC |